Marker patterns of other AML-related differentiation
From haematologyetc.co.uk
Acute erythroid leukaemia (AEL) may be a difficult diagnosis since markers will often not allow cells to be distinguished from a reactive erythroid expansion, and the overlap with cases of myelodysplasia-related AML may have a marked erythroid expansion.
Markers associated with erythroid differentiation in AML | |
---|---|
Most often AML with erythroid maturation will express CD34, while CD45 and HLA-DR is variable but may be weak or negative. CD117 is generally expressed. There may be some expression of megkaryocytic markers in some cases. | |
CD36 | Expression is expected, but often expressed in other subtypes so not fully lineage specific |
CD71 | Frequently expressed though not fully lineage specific |
CD235 | A good marker of erythroid differentiation but acquired late and therefore may not be expressed
|
Markers associated with megakaryocytic differentiation in AML | |
---|---|
Most often CD34, CD45 and HLA-DR are weak or negative, although CD13 and CD33 may be expressed | |
CD41 | Platelet glycoprotein IIbIIIa |
CD61 | Platelet glycoprotein IIIa |
CD36 | Relatively non-specific (seen in erythroid and monocytic leukaemias) but often strongly expressed
|